Cardiotoxicity of trastuzumab in clinical practice

N Engl J Med. 2007 Jul 5;357(1):94-5. doi: 10.1056/NEJMc070065.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Breast Neoplasms / drug therapy
  • Female
  • Humans
  • Stroke Volume / drug effects*
  • Trastuzumab
  • Ventricular Dysfunction, Left / chemically induced*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Trastuzumab